Development of nanomedicine in Hong Kong

Wong, Ken

doi:10.1016/j.nano.2006.10.091

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the field of nanodrug, these countries like USA, Japan, Canada, China, India, Korea, Russia, Singapore, and Switzerland firstly started the research on the drug delivery in early 1980-1990s by employing dendritic nano architecture for the controlled and targeted delivery of anticancer bioactivities. Many laboratories and institutions in these countries also initiated the research and development of nano-drug products since 1990s [46][47][48][49][50][51][52][53][54][55][56][57][58][59].…”

Section: Discussionmentioning

confidence: 99%

Research and Application of Targeting Nano-Drugs

Liu¹

2011

Nano BioMed ENG

View full text Add to dashboard Cite

Nano-drug, a new type drug, is rapidly developing with nanotechnologies in biology and medicine field. The development of nano-drug s will cause the revolution of the diagnosis and treatment. Because Nano-drug carriers have high targeting, favorable sustained, controlled release capability and superior cell penetration ability, it can improve efficacy of drugs and reduce side effects. The role of the object from the target organ, target cell to the most advanced structure in the target cells. The three levels method of targeted therapy all could complete with nanotechnology. Nano-targeting drugs can be divided into passive targeting and active targeting. Current research focuses on the development of functionalized capsules for specific targeting of cancer or immune cells, and on controlling their release properties and targeting functionalities to develop new nano-drugs.

show abstract

Section: Discussionmentioning

confidence: 99%

Research and Application of Targeting Nano-Drugs

Liu¹

2011

Nano BioMed ENG

View full text Add to dashboard Cite

show abstract

“…Finally, the eighth team is exploiting recent advances in electrospinning technology to developing nano-and micro-fibers for tissue engineering applications. With the fast advances of inter-department and international collaboration, we hope to promote and expand nanomedicine in our community [3].…”

Section: Significant Academic Achievementsmentioning

confidence: 99%

“…In the field of nanomedicine, these countries like USA, Japan, Canada, China, India, Korea, Russia, Singapore, and Switzerland firstly started the research on the drug delivery in early 1980-1990s by employing dendritic nano architecture for the controlled and targeted delivery of anticancer bioactivities. Many laboratories and institutions in these countries also initiated the research and development of nanopharmaceutical products since 1990s [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15].…”

Section: Introductionmentioning

confidence: 99%

Research and Development of Nanopharmaceuticals in China

Liu¹

2009

Nano BioMed ENG

View full text Add to dashboard Cite

Nanopharmacoeuticals based on nanomaterials and nanotechnology are medicinal products for drug delivery, nano drugs and nano therapies, in vivo imaging, in vitro diagnostics, biomaterials, and active implants. Nanoscience and nanotechnology in China become ever more consequential in our lives; all members of the scientific community should better inform and educate the public about the great changes this new nano era is likely to bring. Here we review some main advances on the research and development of nanomaterials, nanotechnology and nanopharmaceuticals in China. For nanopharmaceuticals, we focus on the research and application of nanotechnology in anti-cancer drugs, and biological evaluation studies of nanomaterials. Liu is the first among his Chinese peers to apply pharmacokinetics to the research of new drugs. Liu has been in charge f 28 research projects for national key scientific and technological plan, new drug funds and pharmacokinetic study in key projects for National "863" and "973" Plans. Some projects have been listed as the national priority project for key scientific and technological plans, such as "study on the standardization for pharmacokinetics of prodrugs" and "study on the standardization for pharmacokinetics of bio-technical products". In 2003, Liu firstly propose metabonomics studies in China, and organized metabonomics studies of traditional Chinese medicines and bioinformation study. Keywords:

show abstract

Development of nanomedicine in Hong Kong

Cited by 2 publications

References 0 publications

Research and Application of Targeting Nano-Drugs

Research and Application of Targeting Nano-Drugs

Research and Development of Nanopharmaceuticals in China

Contact Info

Product

Resources

About